• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Ljudböcker
  • Pocketböcker
  • Spel och pussel

Pocketfynda! Hundratals böcker för 49 kr/st →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Klinisk medicin och internmedicin
    3. Sjukdomar och rubbningar
    4. Onkologi

    Aptamers Engineered Nanocarriers for Cancer Therapy

    AvPrashant Kesharwani

    Häftad, Engelska, 2022

    Del i serien Woodhead Publishing Series in Biomaterials

    2 574 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Aptamers Engineered Nanocarriers for Cancer Therapy details the selection technologies, biological characteristics, and clinical uses of aptamer-based nano agents for cancer therapeutics. The book helps facilitate speedy solutions for some of the problems pertaining to the manufacture of nano-aptamers - such as toxicity, thermal stability, cost efficiency, tumor penetration and blood stability. Key chapters cover cell-SELEX technology for aptamer selection, mechanisms of multi-drug resistance of cancer, the relevance of aptamers as anticancer therapies, as well as the broad range of aptamer-functionalized nanostructures available.

    This book provides exciting insights into this relatively new approach to cancer therapeutics, and will be of interest to materials scientists, biomedical engineers, molecular biologists, biochemists and clinical scientists, with a focus on cancer therapy.



    • Reviews the mechanisms behind multi-drug resistance (MDR) in cancer and how aptamer-mediated novel therapeutic agents and strategies can facilitate MDR reversal
    • Covers a range of aptamers engineered nanostructures, including PLGA nanoparticles, silica nanoparticles, quantum dots, nucleic acid aptamers, and more
    • Discusses the challenges associated with using aptamers as cancer therapeutics and how this translates into clinical use

    Produktinformation

    • Utgivningsdatum:2022-09-28
    • Mått:152 x 229 x 29 mm
    • Vikt:1 000 g
    • Format:Häftad
    • Språk:Engelska
    • Serie:Woodhead Publishing Series in Biomaterials
    • Antal sidor:556
    • Förlag:Elsevier Science
    • ISBN:9780323858816

    Utforska kategorier

    • Onkologi inom Medicin
    • Biokemisk teknik inom Naturvetenskap och teknik
    • Biomedicinsk teknik inom Medicin

    Mer om författaren

    Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than a decade of teaching, research, and industrial experience across various countries. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has published many articles in well-reputed journals and a large number of books. He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, and “SERB-Ramanujan Fellowship Award”. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

    Innehållsförteckning

    • 1. Cell-SELEX technology for aptamer selection2. Biological characteristics of aptamers3. Mechanisms of multi-drug resistance of cancer4. Relevance of aptamers as targeting ligands for anticancer therapies5. Aptamers as smart ligands for nano-carriers cancer targeting6. Aptamer-functionalized liposomes for targeted cancer therapy7. Aptamer-functionalized micelles for targeted cancer therapy8. Aptamer-functionalized nanoparticles for targeted cancer therapy9. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy10. Aptamer-functionalized silica nanoparticles for targeted cancer therapy11. Aptamer-functionalized gold nanoparticles for targeted cancer therapy12. Aptamer-functionalized dendrimers for targeted cancer therapy13. Aptamer-functionalized carbon nanotubes for targeted cancer therapy14. Aptamer-functionalized quantum dots for targeted cancer therapy15. Cancer immunotherapy via nucleic acid aptamers16. Aptamer-based imaging and diagnostics for cancer cells17. Microdevice-based aptamer sensors18. Aptamer-based microfluidics for circulating tumor cells19. Aptamer-based theranostic approaches for treatment of cancer20. Challenges of aptamers as targeting ligands for anticancer therapies21. Clinical use and future perspective of aptamers